PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sphere of biopharmaceuticals, providing promising progress throughout numerous health-related and industrial programs. With its structural similarity to By natural means derived human serum albumin, OsrHSA presents a safer, additional reputable option for therapeutic us